Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Antimicrobial Resistance and Infection Control|September 25, 2019
A recurrent and transesophageal echocardiography-associated outbreak of extended-spectrum β-lactamase-producing Enterobacter cloacae complex in cardiac surgery patientsTom Van Maerken, Els De Brabandere, Audrey Noël, et al.
Frontiers in Immunology|October 24, 2022
A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccineIsabel Leroux-Roels, Cathy Maes, Jasper Joye, et al.
Human Vaccines & Immunotherapeutics|March 3, 2026
A first-in-human Phase 1/1b randomized trial evaluating the safety and immunogenicity of a respiratory syncytial virus (RSV) virus-like particle subunit vaccine (IVX-121) in healthy young and older adultsIlse De Coster, Isabel Leroux-Roels, Kanchanamala Withanage, et al.
Vaccine|September 19, 2009
Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adultsIsabel Leroux-Roels, Marie Van der Wielen, Froukje Kafeja, et al.
Vaccines|September 27, 2025
A Novel Carbohydrate Fatty-Acid Monosulphate Ester, Squalane-in-Water Adjuvant Is Safe and Enhances Inactivated Influenza Vaccine Immunogenicity in Older AdultsValentino D'Onofrio, Bart Jacobs, Azhar Alhatemi, et al.
Vaccine|January 15, 2020
Persistence of vaccine-elicited immune response up to 14 years post-HIV gp120-NefTat/AS01B vaccinationOlivier Van Der Meeren, Erik Jongert, Kelly E Seaton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2026
Immunogenicity and safety of co-administration of AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine and a COVID-19 mRNA vaccine in adults aged ≥50 years: a phase 3, randomized, non-inferiority trialMarc Bonten, Brandon Essink, Nikita Hanning, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 16, 2023
Epidemiology and molecular typing of multidrug-resistant bacteria in tertiary hospitals and nursing homes in Flanders, BelgiumStefanie van Kleef-van Koeveringe, Veerle Matheeussen, Annette Schuermans, et al.
Antimicrobial Resistance and Infection Control|May 30, 2020
ATP measurement as an objective method to measure environmental contamination in 9 hospitals in the Dutch/Belgian border areaAndreas van Arkel, Ina Willemsen, Linda Kilsdonk-Bode, et al.
Plos One|February 23, 2024
One Health surveillance of colistin-resistant Enterobacterales in Belgium and the Netherlands between 2017 and 2019Sien De Koster, Basil Britto Xavier, Christine Lammens, et al.
Pageof 8